We next used Triacsin C (TriC), a small molecule inhibitor of ACSL 1, 3, 4, and 5 [51] to test the hypothesis that the ACSL family supports myeloma cells in vitro. The gene discussed is MARVELD2; the disease is plasma cell myeloma.